New insights of aquaporin 5 in the pathogenesis of high altitude pulmonary edema
- PMID: 24274330
- PMCID: PMC3937216
- DOI: 10.1186/1746-1596-8-193
New insights of aquaporin 5 in the pathogenesis of high altitude pulmonary edema
Abstract
Background: High altitude pulmonary edema (HAPE) affects individuals and is characterized by alveolar flooding with protein-rich edema as a consequence of blood-gas barrier disruption. In this study, we hypothesized that aquaporin 5 (AQP5) which is one kind of water channels may play a role in preservation of alveolar epithelial barrier integrity in high altitude pulmonary edema (HAPE).
Methods: Therefore, we established a model in Wildtype mice and AQP5 -/- mice were assingned to normoxic rest (NR), hypoxic rest (HR) and hypoxic exercise (HE) group. Mice were produced by training to walk at treadmill for exercising and chamber pressure was reduced to simulate climbing an altitude of 5000 m for 48 hours. Studies using BAL in HAPE mice to demonstrated that edema is caused leakage of albumin proteins and red cells across the alveolarcapillary barrier in the absence of any evidence of inflammation.
Results: In this study, the Lung wet/dry weight ratio and broncholalveolar lavage protein concentrations were slightly increased in HE AQP5 -/- mice compared to wildtype mice. And histologic evidence of hemorrhagic pulmonary edema was distinctly shown in HE group. The lung Evan's blue permeability of HE group was showed slightly increased compare to the wildtype groups, and HR group was showed a medium situation from normal to HAPE development compared with NR and HE group.
Conclusions: Deletion of AQP5 slightly increased lung edema and lung injury compared to wildtype mice during HAPE development, which suggested that the AQP5 plays an important role in HAPE formation induced by high altitude simulation.
Figures





Similar articles
-
Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats.Eur Respir J. 2010 Mar;35(3):584-91. doi: 10.1183/09031936.00001709. Epub 2009 Sep 9. Eur Respir J. 2010. PMID: 19741034
-
Solnatide Demonstrates Profound Therapeutic Activity in a Rat Model of Pulmonary Edema Induced by Acute Hypobaric Hypoxia and Exercise.Chest. 2017 Mar;151(3):658-667. doi: 10.1016/j.chest.2016.10.030. Epub 2016 Nov 1. Chest. 2017. PMID: 27815150
-
KGF-2 targets alveolar epithelia and capillary endothelia to reduce high altitude pulmonary oedema in rats.J Cell Mol Med. 2012 Dec;16(12):3074-84. doi: 10.1111/j.1582-4934.2012.01588.x. J Cell Mol Med. 2012. PMID: 22568566 Free PMC article.
-
High-altitude pulmonary edema.Compr Physiol. 2012 Oct;2(4):2753-73. doi: 10.1002/cphy.c100029. Compr Physiol. 2012. PMID: 23720264 Review.
-
Physiological aspects of high-altitude pulmonary edema.J Appl Physiol (1985). 2005 Mar;98(3):1101-10. doi: 10.1152/japplphysiol.01167.2004. J Appl Physiol (1985). 2005. PMID: 15703168 Review.
Cited by
-
Functional pharmacological characterization of SER100 in cardiovascular health and disease.Br J Pharmacol. 2016 Dec;173(23):3386-3401. doi: 10.1111/bph.13634. Epub 2016 Nov 1. Br J Pharmacol. 2016. PMID: 27667485 Free PMC article.
References
-
- Luo Y, Zou Y, Gao Y. Gene polymorphisms and high-altitude pulmonary edema susceptibility: a 2011 update. Respiration. 2012;8:155–162. - PubMed
-
- Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;8:1284–1289. - PubMed
-
- Maggiorini M. Prevention and treatment of high-altitude pulmonary edema. Prog Cardiovasc Dis. 2010;8:500–506. - PubMed
-
- West JB. The physiologic basis of high-altitude diseases. Ann Intern Med. 2004;8:789–800. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases